High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
Objectives: Lung squamous cell carcinoma (LUSC) is associated with a poor prognosis and a lack of specific treatment options. The dysregulation of activin A (ActA) has been reported in various malignancies. Herein, we investigated the diagnostic and prognostic significance of ActA in LUSC. Materials...
Saved in:
| Main Authors: | Katharina Sinn, Ahmed Elbeialy, Berta Mosleh, Clemens Aigner, Karin Schelch, Viktoria Laszlo, Balazs Dome, Mir Alireza Hoda, Michael Grusch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324002808 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Activins and Inhibins in Cardiovascular Pathophysiology
by: Wenyi Tang, et al.
Published: (2024-11-01) -
Activin levels correlate with lymphocytic infiltration in epithelial ovarian cancer
by: Elizabeth T. Evans, et al.
Published: (2024-09-01) -
Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy
by: Ying Zheng, et al.
Published: (2024-12-01) -
Activin A promoted the anti‐tumor effect of ActRIIA high CD8+ T cells in mouse hepatoma
by: Liangchang Hu, et al.
Published: (2025-01-01) -
Inhibition of Endothelial–Mesenchymal Transition Mediated by Activin Receptor Type IIA Attenuates Valvular Injury Induced by Group A Streptococcus in Lewis Rats
by: Zirong Lu, et al.
Published: (2025-01-01)